Associate Director of Pharmaceutical Development
Stephanie has 12 years of pharmaceutical industry experience and a strong background in product development and specifically, bioavailability enhancement of small molecule formulations. She joined Metrics from the FDA where she reviewed the CMC/Drug Product portions of INDs, NDAs, and industry meeting packages for CDER’s Office of Pharmaceutical Quality. Prior to FDA she spent seven years at UPM Pharmaceuticals, Inc., a then Baltimore-based CDMO, serving as both technical lead and project manager for the development of Pre-clinical through Phase III clinical supplies. She has experience with a wide range of solid oral dosage forms and manufacturing processes, including solubility-enhancing formulations, as well as scale-up, tech transfer, and process validation activities. Stephanie holds a Bachelor of Science in Pharmaceutical Sciences and a doctorate in Industrial & Physical Pharmacy from Purdue University.